These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10573169)

  • 21. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.
    Simbiri KO; Smith NA; Otieno R; Wohlford EE; Daud II; Odada SP; Middleton F; Rochford R
    PLoS One; 2015; 10(5):e0125420. PubMed ID: 25933165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural killer/T-cell lymphoma in the United States.
    Gaal K; Weiss LM; Chen WG; Chen YY; Arber DA
    Lab Invest; 2002 Jul; 82(7):957-62. PubMed ID: 12118098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China.
    Sun L; Zhao Z; Liu S; Liu X; Sun Z; Luo B
    PLoS One; 2015; 10(10):e0140529. PubMed ID: 26460969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.
    Habeshaw G; Yao QY; Bell AI; Morton D; Rickinson AB
    J Virol; 1999 Feb; 73(2):965-75. PubMed ID: 9882297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
    Allday MJ; MacGillivray AJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
    Chen YY; Chang KL; Chen WG; Shibata D; Hayashi K; Weiss LM
    Lab Invest; 1998 Jul; 78(7):877-82. PubMed ID: 9690565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
    Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
    J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
    Aitken C; Sengupta SK; Aedes C; Moss DJ; Sculley TB
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():95-100. PubMed ID: 8113744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
    Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
    Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
    Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
    J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.
    Razzouk BI; Srinivas S; Sample CE; Singh V; Sixbey JW
    J Infect Dis; 1996 Mar; 173(3):529-35. PubMed ID: 8627013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.
    Silins SL; Sculley TB
    Int J Cancer; 1995 Jan; 60(1):65-72. PubMed ID: 7814154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent presence of subtype A virus in Epstein-Barr virus-associated malignancies.
    Peh SC; Kim LH; Poppema S
    Pathology; 2002 Oct; 34(5):446-50. PubMed ID: 12408344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.